搜索头条

“mounjaro”

Zepbound and Mounjaro may turn on the body’s calorie-burning brown fat

Tirzepatide, sold as Mounjaro and Zepbound, activated calorie-burning brown fat in obese mice, revealing a potential metabolic effect beyond appetite suppression. If confirmed in humans, the finding could help explain the drug’s powerful benefits and inspire more comprehensive tr

All Top News -- ScienceDaily · 2026年9月26日 12:31

科学与环境

Stopping Ozempic may raise heart attack and stroke risk

A large study suggests the cardiovascular benefits of GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound can disappear surprisingly quickly when treatment stops. After two years off the medications, patients had a 22% higher risk of heart attack, stroke, and death compar

All Top News -- ScienceDaily · 2026年9月21日 13:35